Karen Welch

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.

J. Thompson Coon, K. Stein, M. Hoyle, 2010, Health technology assessment.

The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation.

M. Pitt, K. Stein, R. Garside, 2007, Health technology assessment.